R&D channel feed – Endpoints News

R&D channel feed

Eli Lilly reports first Phase 3 data for oral GLP-1, posting a win in diabetes

4 weeks ago

CDC advisors broaden RSV vaccine recommendations to at-risk adults in their 50s

4 weeks ago

Glycomine raises $115M to see if it can treat rare glycosylation disorder

4 weeks ago

Mural Oncology ends clinical development, lays off most workers

4 weeks ago

Sanofi’s Kymab-originated inflammatory drug flunks mid-stage asthma trial

4 weeks ago

FDA clears clinical trial of gene-edited pig liver used outside of body

4 weeks ago

Merck explores potential of oral peptides in deal with Austrian biotech

4 weeks ago

Siddhartha Mukherjee’s cell therapy startup narrows focus as staff shrinks

4 weeks ago

Trump pharma tariffs inch closer as administration confirms US trade probe

4 weeks ago

Bristol Myers says Camzyos fails Phase 3 study in genetic heart condition

4 weeks ago

CDC vaccine advisors are set to meet this week after two-month delay and scrutiny from Kennedy

4 weeks ago

Primate researchers cope with uncertainty as NIH appeals for payment cuts in court

4 weeks ago

Verve unveils early data from second attempt at heart disease gene editing

4 weeks ago

In a blow to its obesity pipeline, Pfizer drops oral drug after liver injury case

4 weeks ago

Makary wants to replace animal testing with organoids. It may take a while

5 weeks ago

Bristol Myers' immunotherapy combo nets approvals in colorectal and liver cancer

5 weeks ago

Tome Bio founders wrangle ‘jumping genes’ to create new programmable gene insertion tool

5 weeks ago

J&J, argenx keep rolling out myasthenia gravis data, plus more from #AAN25

5 weeks ago

Alzheon’s amyloid-targeting pill fails another Phase 3 study in Alzheimer’s

5 weeks ago

Q&A: Lundbeck’s head of R&D on letting ‘biology speak’ in neuroscience

Last month

Cartesian reveals long-term mid-stage data for cell therapy in myasthenia gravis

Last month

Rhythm touts Phase 3 win for rare obesity drug in people with brain damage

Last month

Novavax’s held-up approval package may signal warning for Covid vaccine makers

Last month

Secretive Chinese startup begins first-ever clinical trial of circular RNA therapy

Last month

First page Previous page 1 234 5 6 Next page Last page